• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Tumor immune evasion by Galectin-3

Research Project

Project/Area Number 24791774
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Otorhinolaryngology
Research InstitutionOsaka University

Principal Investigator

HANAMOTO Atsushi  大阪大学, 医学部附属病院, 医員 (20625917)

Project Period (FY) 2012-04-01 – 2014-03-31
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywordsガレクチン3
Research Abstract

We obtained cell lines of head and neck squamous carcinomas (FaDu, Detroit562, BICR6,BICR18). They were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. We obtained reagents and instruments to perform proliferation assay, DC protein assay, immunocytochemistry stain and flow cytometory. Proliferation assay was performed. Cells were plated in 96-well plates (1,000 cells per well) were grown in their respective media for 24, 48, or 72 hours. FaDu proliferated faster than the other cell lines. DC protein assay was performed to detect the concentration of the protein in lysate of the cell lines. We performed SDS-PAGE and Western blot analysis. Western blotting revealed that FaDu, Detroit562 and BICR6 had high expression of Galectin-3.

Report

(3 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • Research Products

    (12 results)

All 2014 2013 2012

All Journal Article (2 results) (of which Peer Reviewed: 1 results) Presentation (10 results)

  • [Journal Article] Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer2013

    • Author(s)
      Hanamoto A, Takenaka Y, Shimosegawa E, Yamamoto Y, Yoshii T, Nakahara S, Hatazawa J, Inohara H
    • Journal Title

      Ann Nucl Med

    • Related Report
      2013 Final Research Report
  • [Journal Article] Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.2013

    • Author(s)
      Hanamoto A, Takenaka Y, Shimosegawa E, Yamamoto Y, Yoshii T, Nakahara S, Hatazawa J, Inohara H.
    • Journal Title

      Ann Nucl Med.

      Volume: 27 Issue: 10 Pages: 880-5

    • DOI

      10.1007/s12149-013-0765-x

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Presentation] 18F-FDG PET/CT より得られる腫瘍代謝容積の検討2014

    • Author(s)
      花本敦
    • Organizer
      第24回日本頭頸部外科学会
    • Place of Presentation
      高松
    • Related Report
      2013 Final Research Report
  • [Presentation] PERCIST1.0 and RECIST1.1 in evaluating treatment response to chemoradiotherapy in primary and metastatic lymph node lesions of hypopharyngeal carcinoma2013

    • Author(s)
      Hanamoto A, Tatsumi M, Kato H, Shimosegawa E, Inohara H, Hatazawa J
    • Organizer
      60th Annual meeting Society of Nuclear Medicine
    • Place of Presentation
      Vancouver, Canada
    • Related Report
      2013 Annual Research Report 2013 Final Research Report
  • [Presentation] Metabolic tumor volume on pretreatment FDG-PET predicts clinical outcome in head and neck squamous cell carcinoma receiving chemoradiotherapy2012

    • Author(s)
      Hanamoto A, Tatsumi M, Watabe T, Kato H, Shimosegawa E, Inohara H, Hatazawa J
    • Organizer
      59th Annual meeting Society of Nuclear Medicine
    • Place of Presentation
      Miami Beach, U.S.A
    • Related Report
      2013 Final Research Report
  • [Presentation] Metabolic Tumor Volume is the best predictor of larynx preservation in patients with hypopharyngeal carcinoma receiving chemoradiothrapy2012

    • Author(s)
      Hanamoto A, Tatsumi M, Watabe T, Kato H, Shimosegawa E, Inohara H, Hatazawa J
    • Organizer
      59th Annual meeting Society of Nuclear Medicine
    • Place of Presentation
      Miami Beach, U.S.A
    • Related Report
      2013 Final Research Report
  • [Presentation] 下咽頭癌の化学放射線療法の予後予測のための容積測定に関する検討2012

    • Author(s)
      花本敦, 山本佳史, 喜井正士, 竹中幸則, 中原晋, 安井俊道, 福角隆仁, 猪原秀典
    • Organizer
      第36回日本頭頸部癌学会
    • Place of Presentation
      松江
    • Related Report
      2013 Final Research Report
  • [Presentation] 化学放射線療法前のFDG-PET より得られる定量的な数値の検討2012

    • Author(s)
      花本敦, 山本佳史, 喜井正士, 竹中幸則, 中原晋, 安井俊道, 福角隆仁, 猪原秀典
    • Organizer
      第36回日本頭頸部癌学会
    • Place of Presentation
      松江
    • Related Report
      2013 Final Research Report
  • [Presentation] 下咽頭癌の化学放射線療法の予後予測のための容積測定に関する検討2012

    • Author(s)
      花本敦
    • Organizer
      頭頸部癌学会
    • Place of Presentation
      松江
    • Related Report
      2012 Research-status Report
  • [Presentation] 化学放射線療法前のFDG-PETより得られる定量的な数値の検討2012

    • Author(s)
      花本敦
    • Organizer
      頭頸部癌学会
    • Place of Presentation
      松江
    • Related Report
      2012 Research-status Report
  • [Presentation] Metabolic tumor volume on pretreatment FDG-PET predicts clinical outcome in head and neck squamous cell carcinoma receiving chemoradiotherapy2012

    • Author(s)
      花本敦
    • Organizer
      米国核医学会
    • Place of Presentation
      マイアミ
    • Related Report
      2012 Research-status Report
  • [Presentation] Metabolic Tumor Volume is the best predictor of larynx preservation in patients with hypopharyngeal carcinoma receiving chemoradiothrapy2012

    • Author(s)
      花本敦
    • Organizer
      米国核医学会
    • Place of Presentation
      マイアミ
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi